Archives
-
Nitrocefin for Reliable β-Lactamase Assays
2026-09-30
Learn how Nitrocefin SKU B6052 supports interpretable β-lactamase detection, inhibitor screening, and antibiotic-resistance workflows without being mistaken for a direct cell-viability reagent. This scenario-based guide covers compatibility, protocol controls, data interpretation, storage, and supplier selection.
-
Mitochondrial IRF3 in Bleomycin Lung Fibrosis
2026-09-30
The 2026 Cellular Signalling study identifies mitochondrial IRF3 as a mechanistic link between cGAS-STING activation, defective PINK1-associated mitophagy, and ferroptosis in pulmonary fibrosis. Its combined mouse and A549-cell experiments suggest that blocking IRF3 mitochondrial translocation or upstream STING activity can reduce epithelial injury and fibrotic progression, while also defining important limits for model interpretation.
-
Purmorphamine Workflows for Smoothened Signaling
2026-09-29
Purmorphamine is a receptor-proximal Smoothened agonist for connecting Hedgehog pathway activation with osteogenic, neural, and sensory readouts. This practical guide covers dose planning, cross-species assay design, workflow controls, and troubleshooting for more reproducible experiments.
-
Nanotube-Shaped Peptide Vehicles for mRNA Delivery
2026-09-29
The reference chapter presents a structure-controlled strategy for packaging mRNA into nanotube-shaped vehicles built from self-assembling peptide units. Its main contribution is a detailed design, formulation, and characterization workflow that connects peptide supramolecular chemistry with mRNA delivery, while also identifying the experiments needed to test stability and intracellular performance.
-
Mitomycin C Workflows for Cancer Research
2026-09-28
Mitomycin C combines DNA replication inhibition with strong utility in apoptosis and chemotherapy-sensitization assays. This guide translates its chemistry into reproducible cell-based workflows and shows how to interpret it alongside the DC–CD8+ T-cell and NK-cell strategy described in the reference study.
-
Cytoskeleton-Dependent Autophagy Under Compression
2026-09-28
The study shows that cytoskeletal microfilaments are required for compression-induced changes in autophagosome number, while microtubules make an auxiliary contribution. Its perturbation-based approach strengthens the case that the cytoskeleton participates directly in mechanical signal transmission, while leaving autophagic flux and the intervening molecular signals open for further testing.
-
αKG–Carnitine Signaling Supports DNA Repair
2026-09-27
The study identifies an α-ketoglutarate (αKG)-dependent carnitine synthesis pathway that promotes histone acetylation and homologous recombination (HR) repair, helping HR-proficient cancer cells withstand DNA-damaging treatments. Its findings connect metabolic state with repair capacity and suggest a route for investigating treatment sensitivity, while leaving clinical translation and causal interpretation of patient associations open.
-
Mitomycin C Workflows for Apoptosis Research
2026-09-26
Use Mitomycin C to connect DNA damage and replication stress with cell viability and apoptosis readouts, then test whether it sensitizes selected tumor models to TRAIL. This practical workflow distinguishes product-supported findings from pilot conditions and uses a B-cell selection study to sharpen assay design—not to imply an untested drug mechanism.
-
Cycloastragenol Limits Bone Loss in GIONFH
2026-09-25
In a rat model of glucocorticoid-induced osteonecrosis of the femoral head, cycloastragenol reduced necrotic lesion area and trabecular bone loss while improving local blood supply. The study links these tissue-level benefits with lower osteoclast-related gene and protein markers, supporting further investigation of osteoclast inhibition as a hip-preservation strategy—not yet establishing clinical efficacy.
-
Nipah Virus Polymerase: Structure and Replication Insights
2026-09-25
The reference study reports cryo-EM and crystallographic structures that clarify how Nipah virus polymerase components are organized and how the P protein associates with the L protein. These structural observations provide a foundation for investigating viral RNA synthesis and designing experiments to test polymerase-directed antiviral strategies, while not establishing the activity of any candidate compound against Nipah virus.
-
Salidroside, Autophagy, and Axonal Sprouting After Stroke
2026-09-24
A December 2024 study reports that salidroside reduced injury in experimental ischemic stroke models while increasing axonal sprouting and changing autophagy-related readouts. Blocking autophagy-associated signaling with 3-MA weakened these effects, supporting a mechanistic link while leaving questions about pathway specificity and functional neural repair open.
-
Dehydroabietic Acid in Cell Assay Workflows
2026-09-24
A practical guide to using Dehydroabietic acid (SKU N2850) in cell viability and proliferation experiments, with attention to vehicle controls, compound handling, and interpretation of metabolic readouts. It distinguishes product specifications from unestablished biological dose recommendations so researchers can design more interpretable metabolic disorder research.
-
Nitrocefin: β-Lactamase Assay Substrate
2026-09-23
Nitrocefin is a chromogenic cephalosporin substrate that changes from yellow to red when hydrolyzed by β-lactamase, supporting colorimetric β-lactamase assay workflows. This article summarizes its product-reported properties, research uses, limitations, and how substrate-based activity measurements complement—not replace—inhibitor discovery.
-
Troglitazone PPARγ Agonist Workflows
2026-09-23
Build reproducible Troglitazone workflows that separate PPARγ target engagement, metabolic responses, renal carcinoma cytotoxicity, and macrophage-state remodeling. The approach combines practical dose-response design with a cautious, hypothesis-driven extension into SPP1-focused tumor-myeloid assays.
-
ZCL278: A Cdc42 Assay-to-Phenotype Framework
2026-09-22
ZCL278 is a selective Cdc42 inhibitor for connecting biochemical target engagement with cell motility, neuronal morphology, and fibrosis-related signaling. This article presents an evidence-graded workflow that uses kidney fibrosis research to sharpen assay interpretation without overstating ZCL278’s therapeutic relevance.